Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02165215
Brief Title: A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors (LAUREL)

First Submitted : June 13, 2014
First Submitted that Met QC Criteria : June 16, 2014
First Posted : June 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 16, 2020
Last Update Posted : January 18, 2020